ALPS Medical Breakthroughs ETF SBIO
55.78 USD +2.95 (+5.58%)
At closeNov 6, 2026, 4:00 PM EST
55.78 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
53.34 Day range 55.78
44.13 52-week range 70.79
- YTD
- +8.90%
- 1 year
- +26.00%
News
benzinga.com Kymera Therapeutics Stock Climbs On Accelerated Timeline For Lead Atopic Dermatitis Program Kymera Therapeutics shares surged after completing KT-621 Phase 2b enrollment early, accelerating data timing and Phase 3 plans.
benzinga.com Apogee Stock Slides After Blackstone Financing Deal And Positive Drug Data Apogee shares fell after announcing a $1.3 billion Blackstone financing deal alongside positive Phase 2 eczema drug results.
benzinga.com Structure Therapeutics Stock Explodes As Much-Awaited Experimental Oral Drug Trial Shows Weight Loss Of 16% Structure Therapeutics' Phase 2 ACCESS II trial shows up to 16.3% placebo-adjusted weight loss for obesity drug aleniglipron.
benzinga.com Psychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology Index Psilocybin-focused mental health care company COMPASS Pathways plc (NASDAQ: CMPS) revealed Friday that it has been selected for addition to the Nasdaq Biotechnology Index (NASDAQ: NBI), effective as…
benzinga.com Exclusive: SunTrust Managing Director Discusses Bluebird Bio, A Leader In Gene Therapy